"The whole idea is to try to reign in the inappropriate advertising and use of these drugs," said Dr. Michael Domanski, the director of heart failure research at Mount Sinai School of Medicine, following an FDA committee meeting to discuss testosterone. Dr. Domanski was one of 20 experts who voted in favor of strict new limitations on the multi-billion-dollar testosterone drug industry.
The changes will tighten labels for testosterone medications, like AndroGel, so they are not prescribed to men who only have problems related to aging, such as low energy and libido. Once used to treat serious medical conditions, testosterone is now taken by over two million American men, mostly for symptoms that are largely the result of aging.
Medical experts are alarmed that testosterone is now being prescribed for "low-T" or side effects of aging. "I'm glad to see the ship is turning," said Dr. Aaron Katz, chairman of the Department of Urology at Winthrop University Hospital. "Clearly the explosion of testosterone prescriptions have caught the attention of the FDA and many are now realizing the impact that this could have."
Men who are looking for the fountain of youth are instead experiencing serious injuries. Multiple studies have linked testosterone use with congestive heart failure, heart attacks, strokes, pulmonary embolism, blood clots and bone death. Many of these men are pursuing testosterone lawsuits.
If you or a loved one had a heart attack, congestive heart failure, stroke, pulmonary embolism, blood clot or bone death while taking testosterone, please call our experienced AndroGel attorneys at (888) 606-5297 for a free consultation about your potential AndroGel lawsuit.